TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,615 | -73.9% | 20,203 | -55.1% | 0.00% | -71.4% |
| Q2 2023 | $691,247 | -38.2% | 45,003 | -9.5% | 0.01% | -36.4% |
| Q1 2023 | $1,117,822 | +7.4% | 49,703 | +0.4% | 0.02% | +10.0% |
| Q4 2022 | $1,041,049 | +9.6% | 49,503 | +28.5% | 0.02% | +5.3% |
| Q3 2022 | $950,000 | +157.5% | 38,515 | +153.4% | 0.02% | +171.4% |
| Q2 2022 | $369,000 | -20.6% | 15,200 | -18.3% | 0.01% | +40.0% |
| Q1 2021 | $465,000 | -15.0% | 18,615 | -7.0% | 0.01% | -16.7% |
| Q4 2020 | $547,000 | – | 20,015 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |